Paratek Pharmaceuticals Inc expected to post a loss of 45 cents a share - Earnings Preview

Paratek Pharmaceuticals

01/11/2021 23:00

* Paratek Pharmaceuticals Inc  PRTK.OQ   PRTK.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 3 (estimated). 
* The Boston, Massachusetts-based company is expected to report 
a 74.4% increase in revenue to $23.817 million from $13.66
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Paratek Pharmaceuticals
Inc is for a loss of 45 cents per share. For the same quarter
last year, the company reported a loss of 46 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $21.5​, about 75.8% above​ its last
closing price of $5.20. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   0.35        0.32       0.20      Missed  -36.5
 Mar. 312021   -0.40       -0.38      -0.39     Missed  -2.1
 Dec. 312020   -0.12       -0.04      -0.60     Missed  -1,233
                                                        .3​
 Sep. 302020   -0.61       -0.61      -0.46     Beat    24.6
 ​​Jun.        -0.23       -0.06      -0.53     Missed  -748
 302020                                                 
 Mar. 312020   -0.88       -0.80      -0.66     Beat    17.8​
 Dec. 312019   -0.75       -0.81      -0.81     Met     -0.2
 Sep. 302019   -1.04       -1.05      -1.00     Beat    4.5
 This summary was machine generated November 1 at 23:00 GMT.  All
figures in US dollars unless otherwise stated